Research programme: reperfusion injury therapies - GENOPIA Biomedical
Alternative Names: Reperfusion injury therapies research programme - GENOPIA BiomedicalLatest Information Update: 24 Feb 2010
At a glance
- Originator GENOPIA Biomedical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Reperfusion injury; Stroke
Most Recent Events
- 24 Feb 2010 Discontinued - Preclinical for Reperfusion injury in Germany (unspecified route)
- 24 Feb 2010 Discontinued - Preclinical for Stroke in Germany (unspecified route)
- 04 Aug 2004 Compounds are available for licensing (http://www.genopia.de)